Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuanxin Liu

Showing results (81-90 of 130) with videos related to

Pageof 13
Sort By:
Frontiers in Pharmacology|May 17, 2021
Global Analysis the Potential Medicinal Substances of Shuangxia Decoction and the Process <i>In Vivo</i> via Mass Spectrometry TechnologyChenning Zhang, Chuanxin Liu, Hao Wu, et al.
Journal of Molecular Histology|May 25, 2026
An integrated multi-omics approach for deciphering podophyllotoxin-induced nephrotoxicity via the microbiome-gut-kidney (MGK) axis based on the toxicological evidence (TEC) conceptXiaole Guo, Yu Wang, Lei Wang, et al.
Frontiers in Molecular Neuroscience|February 28, 2019
Double-Edged Sword of Tumour Suppressor Genes in SchizophreniaChuanjun Zhuo, Dawei Wang, Chunhua Zhou, et al.
Psychology Research and Behavior Management|January 5, 2026
Influence of Inter-Parental Conflict on New-Onset Major Depressive Disorder in Chinese College StudentsYan Gao, Qing Fang, Yanan Zhou, et al.
Frontiers in Pharmacology|November 8, 2019
Surprising Anticancer Activities of Psychiatric Medications: Old Drugs Offer New Hope for Patients With Brain CancerChuanjun Zhuo, Zhiyuan Xun, Weihong Hou, et al.
Psychiatry and Clinical Psychopharmacology|May 20, 2024
Left Cerebral Cortex Complexity in Patients with Major Depression Disorder: A Small-Sample Pilot StudyJian Liu, Xinying Chen, Chuanxin Liu, et al.
Future Oncology (London, England)|May 2, 2020
Analysis of differential metabolites in lung cancer patients based on metabolomics and bioinformaticsChenchen Zhao, Xianbin Kong, Shuang Han, et al.
Molecular Medicine Reports|March 24, 2021
A combination of PD‑1/PD‑L1 inhibitors: The prospect of overcoming the weakness of tumor immunotherapy (Review)Xianbin Kong, Peng Lu, Chuanxin Liu, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 13, 2018
Schizophrenia and gut-flora related epigenetic factorsChuanjun Zhuo, Yudong Yao, Yong Xu, et al.
Brain and Behavior|May 6, 2026
Regional Brain Activity Alterations in Social Anxiety Disorder Revealed by Seed-Based d Mapping With Permutation of Subject ImagesSen Li, Ziqi Zhang, Shanling Ji, et al.
Pageof 13

Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Frontiers in Pharmacology|May 17, 2021
Global Analysis the Potential Medicinal Substances of Shuangxia Decoction and the Process <i>In Vivo</i> via Mass Spectrometry TechnologyChenning Zhang, Chuanxin Liu, Hao Wu, et al.
Journal of Molecular Histology|May 25, 2026
An integrated multi-omics approach for deciphering podophyllotoxin-induced nephrotoxicity via the microbiome-gut-kidney (MGK) axis based on the toxicological evidence (TEC) conceptXiaole Guo, Yu Wang, Lei Wang, et al.
Frontiers in Molecular Neuroscience|February 28, 2019
Double-Edged Sword of Tumour Suppressor Genes in SchizophreniaChuanjun Zhuo, Dawei Wang, Chunhua Zhou, et al.
Psychology Research and Behavior Management|January 5, 2026
Influence of Inter-Parental Conflict on New-Onset Major Depressive Disorder in Chinese College StudentsYan Gao, Qing Fang, Yanan Zhou, et al.
Frontiers in Pharmacology|November 8, 2019
Surprising Anticancer Activities of Psychiatric Medications: Old Drugs Offer New Hope for Patients With Brain CancerChuanjun Zhuo, Zhiyuan Xun, Weihong Hou, et al.
Psychiatry and Clinical Psychopharmacology|May 20, 2024
Left Cerebral Cortex Complexity in Patients with Major Depression Disorder: A Small-Sample Pilot StudyJian Liu, Xinying Chen, Chuanxin Liu, et al.
Future Oncology (London, England)|May 2, 2020
Analysis of differential metabolites in lung cancer patients based on metabolomics and bioinformaticsChenchen Zhao, Xianbin Kong, Shuang Han, et al.
Molecular Medicine Reports|March 24, 2021
A combination of PD‑1/PD‑L1 inhibitors: The prospect of overcoming the weakness of tumor immunotherapy (Review)Xianbin Kong, Peng Lu, Chuanxin Liu, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 13, 2018
Schizophrenia and gut-flora related epigenetic factorsChuanjun Zhuo, Yudong Yao, Yong Xu, et al.
Brain and Behavior|May 6, 2026
Regional Brain Activity Alterations in Social Anxiety Disorder Revealed by Seed-Based d Mapping With Permutation of Subject ImagesSen Li, Ziqi Zhang, Shanling Ji, et al.
Pageof 13